Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Nuclear Medicines Radioisotopes industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Bayer AG
Nordion Inc (Sotera Health Company)
GE Healthcare
NTP Radioisotopes SOC Ltd
By Type:
Actinium-225 (Ac-225)
Other Types of Radioisotopes
Radium-223 (Ra-223) and Alpharadin
Fluorine-18
Iodine-131 (I-131)
Thallium-201 (Tl-201)
Lutetium-177 (Lu-177)
Iodine (I-123)
Technetium-99m (Tc-99m)
Rubidium-82 (Rb-82)
By Application:
Oncology
Other Applications
Thyroid
Cardiology
Neurology
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Nuclear Medicines Radioisotopes Market Overview 2018-2029
-
1.1 China Nuclear Medicines Radioisotopes Industry Development Overview
-
1.2 China Nuclear Medicines Radioisotopes Industry Development History
-
1.3 China Nuclear Medicines Radioisotopes Industry Market Size (2018-2029)
-
1.4 China Nuclear Medicines Radioisotopes Market Analysis by Type from Production Side
-
1.4.1 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Actinium-225 (Ac-225) (2018-2029)
-
1.4.2 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Other Types of Radioisotopes (2018-2029)
-
1.4.3 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Radium-223 (Ra-223) and Alpharadin (2018-2029)
-
1.4.4 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Fluorine-18 (2018-2029)
-
1.4.5 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Iodine-131 (I-131) (2018-2029)
-
1.4.6 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Thallium-201 (Tl-201) (2018-2029)
-
1.4.7 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Lutetium-177 (Lu-177) (2018-2029)
-
1.4.8 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Iodine (I-123) (2018-2029)
-
1.4.9 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Technetium-99m (Tc-99m) (2018-2029)
-
1.4.10 China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Rubidium-82 (Rb-82) (2018-2029)
-
1.5 China Nuclear Medicines Radioisotopes Market Analysis by Application from Consumption End
-
1.5.1 China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
1.5.2 China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Other Applications (2018-2029)
-
1.5.3 China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Thyroid (2018-2029)
-
1.5.4 China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)
-
1.5.5 China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Neurology (2018-2029)
-
1.6 China Nuclear Medicines Radioisotopes Market Analysis by Region
-
1.6.1 North China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
Chapter 2 China Nuclear Medicines Radioisotopes Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Nuclear Medicines Radioisotopes Market Status and Competition at home and abroad in 2023
-
2.2.2 China Nuclear Medicines Radioisotopes Market Status and Competition Analysis in 2023
-
2.2.3 China Nuclear Medicines Radioisotopes Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Nuclear Medicines Radioisotopes Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Nuclear Medicines Radioisotopes Industry Development
Chapter 3 Nuclear Medicines RadioisotopesIndustry Chain Analysis
-
3.1 Nuclear Medicines Radioisotopes Industry Chain
-
3.2 Nuclear Medicines Radioisotopes Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Nuclear Medicines Radioisotopes Market
-
3.3 Nuclear Medicines Radioisotopes Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Nuclear Medicines Radioisotopes Market
Chapter 4 China Nuclear Medicines Radioisotopes Market, by Type
-
4.1 China Nuclear Medicines Radioisotopes Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Nuclear Medicines Radioisotopes Total Production Volume and Growth Rate from Production Side
-
4.5 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate, by Type
-
4.5.1 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Actinium-225 (Ac-225)
-
4.5.2 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Other Types of Radioisotopes
-
4.5.3 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Radium-223 (Ra-223) and Alpharadin
-
4.5.4 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Fluorine-18
-
4.5.5 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Iodine-131 (I-131)
-
4.5.6 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Thallium-201 (Tl-201)
-
4.5.7 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Lutetium-177 (Lu-177)
-
4.5.8 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Iodine (I-123)
-
4.5.9 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Technetium-99m (Tc-99m)
-
4.5.10 China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Rubidium-82 (Rb-82)
Chapter 5 China Nuclear Medicines Radioisotopes Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Nuclear Medicines Radioisotopes Total Market Size and Growth Rate from Consumption End
-
5.5 China Nuclear Medicines Radioisotopes Market Size and Growth Rate, by Application
-
5.5.1 China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Oncology
-
5.5.2 China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Other Applications
-
5.5.3 China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Thyroid
-
5.5.4 China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Cardiology
-
5.5.5 China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Neurology
Chapter 6 China Nuclear Medicines Radioisotopes Market, by Region
-
6.1 China Nuclear Medicines Radioisotopes Production Volume and Production Value, by Region
-
6.2 China Nuclear Medicines Radioisotopes Sales Volume and Sales Value, by Region
Chapter 7 North China Nuclear Medicines Radioisotopes Market Analysis
-
7.1 North China Nuclear Medicines Radioisotopes Market, by Type
-
7.2 North China Nuclear Medicines Radioisotopes Market, by Application
Chapter 8 Central China Nuclear Medicines Radioisotopes Market Analysis
-
8.1 Central China Nuclear Medicines Radioisotopes Market, by Type
-
8.2 Central China Nuclear Medicines Radioisotopes Market, by Application
Chapter 9 South China Nuclear Medicines Radioisotopes Market Analysis
-
9.1 South China Nuclear Medicines Radioisotopes Market, by Type
-
9.2 South China Nuclear Medicines Radioisotopes Market, by Application
Chapter 10 East China Nuclear Medicines Radioisotopes Market Analysis
-
10.1 East China Nuclear Medicines Radioisotopes Market, by Type
-
10.2 East China Nuclear Medicines Radioisotopes Market, by Application
Chapter 11 Northeast China Nuclear Medicines Radioisotopes Market Analysis
-
11.1 Northeast China Nuclear Medicines Radioisotopes Market, by Type
-
11.2 Northeast China Nuclear Medicines Radioisotopes Market, by Application
Chapter 12 Southwest China Nuclear Medicines Radioisotopes Market Analysis
-
12.1 Southwest China Nuclear Medicines Radioisotopes Market, by Type
-
12.2 Southwest China Nuclear Medicines Radioisotopes Market, by Application
Chapter 13 Northwest China Nuclear Medicines Radioisotopes Market Analysis
-
13.1 Northwest China Nuclear Medicines Radioisotopes Market, by Type
-
13.2 Northwest China Nuclear Medicines Radioisotopes Market, by Application
Chapter 14 Company Profiles
-
14.1 Bayer AG
-
14.1.1 Bayer AG Company Profile
-
14.1.2 Bayer AG Nuclear Medicines Radioisotopes Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Nordion Inc (Sotera Health Company)
-
14.2.1 Nordion Inc (Sotera Health Company) Company Profile
-
14.2.2 Nordion Inc (Sotera Health Company) Nuclear Medicines Radioisotopes Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GE Healthcare
-
14.3.1 GE Healthcare Company Profile
-
14.3.2 GE Healthcare Nuclear Medicines Radioisotopes Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 NTP Radioisotopes SOC Ltd
-
14.4.1 NTP Radioisotopes SOC Ltd Company Profile
-
14.4.2 NTP Radioisotopes SOC Ltd Nuclear Medicines Radioisotopes Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Nuclear Medicines Radioisotopes Industry Research Conclusions
-
15.2 Nuclear Medicines Radioisotopes Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Nuclear Medicines Radioisotopes Industry Market Size (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Actinium-225 (Ac-225) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Other Types of Radioisotopes (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Radium-223 (Ra-223) and Alpharadin (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Fluorine-18 (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Iodine-131 (I-131) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Thallium-201 (Tl-201) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Lutetium-177 (Lu-177) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Iodine (I-123) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Technetium-99m (Tc-99m) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Production Volume, Production Value and Growth Rate of Rubidium-82 (Rb-82) (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Other Applications (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Thyroid (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)
-
Figure China Nuclear Medicines Radioisotopes Sales Volume, Sales Value and Growth Rate of Neurology (2018-2029)
-
Figure North China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure Central China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure South China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure East China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Nuclear Medicines Radioisotopes Market Size and Growth Rate from 2018-2029
-
Figure Nuclear Medicines Radioisotopes Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Nuclear Medicines Radioisotopes Market Share by Type in 2018
-
Figure China Nuclear Medicines Radioisotopes Market Share by Type in 2023
-
Figure China Nuclear Medicines Radioisotopes Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Actinium-225 (Ac-225) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Other Types of Radioisotopes (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Radium-223 (Ra-223) and Alpharadin (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Fluorine-18 (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Iodine-131 (I-131) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Thallium-201 (Tl-201) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Lutetium-177 (Lu-177) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Iodine (I-123) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Technetium-99m (Tc-99m) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume and Growth Rate of Rubidium-82 (Rb-82) (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Market Share by Application in 2018
-
Figure China Nuclear Medicines Radioisotopes Market Share by Application in 2023
-
Figure China Nuclear Medicines Radioisotopes Total Market Size and Growth Rate from Consumption End
-
Figure China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Oncology (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Other Applications (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Thyroid (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Cardiology (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Market Size and Growth Rate of Neurology (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Production Volume by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Production Volume Share by Region (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Volume Share by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Production Value by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Production Value Share by Region (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Production Value Share by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Sales Volume by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Sales Volume Share by Region (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Sales Volume Share by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Sales Value by Region (2018-2023)
-
Table China Nuclear Medicines Radioisotopes Sales Value Share by Region (2018-2023)
-
Figure China Nuclear Medicines Radioisotopes Sales Value Share by Region (2018-2023)
-
Table North China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table North China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure North China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table North China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table North China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure North China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table Central China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table Central China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure Central China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table Central China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table Central China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure Central China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table South China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table South China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure South China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table South China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table South China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure South China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table East China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table East China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure East China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table East China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table East China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure East China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table Northeast China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table Northeast China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure Northeast China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table Northeast China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table Northeast China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table Southwest China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table Southwest China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure Southwest China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table Southwest China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table Southwest China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table Northwest China Nuclear Medicines Radioisotopes Production Volume by Type (2018-2023)
-
Table Northwest China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Figure Northwest China Nuclear Medicines Radioisotopes Production Volume Share by Type (2018-2023)
-
Table Northwest China Nuclear Medicines Radioisotopes Sales Volume by Application (2018-2023)
-
Table Northwest China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Nuclear Medicines Radioisotopes Sales Volume Share by Application (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Nuclear Medicines Radioisotopes Revenue, Price and Gross (2018-2023)
-
Table Nordion Inc (Sotera Health Company) Company Profile
-
Table Nordion Inc (Sotera Health Company) Nuclear Medicines Radioisotopes Revenue, Price and Gross (2018-2023)
-
Table GE Healthcare Company Profile
-
Table GE Healthcare Nuclear Medicines Radioisotopes Revenue, Price and Gross (2018-2023)
-
Table NTP Radioisotopes SOC Ltd Company Profile
-
Table NTP Radioisotopes SOC Ltd Nuclear Medicines Radioisotopes Revenue, Price and Gross (2018-2023)
-
